Virax Biolabs VRAX
NASDAQ VRAX
$2.18 0.00 (-0.18%)
As of: Oct 1, 2026 · 9:40 AM EDT

Virax Biolabs (VRAX) Finished Goods (2024 - 2025)

Updated

Virax Biolabs (VRAX) reported Finished Goods of $46,904 for fiscal Q4 2025 (quarter ended Mar 31, 2025), down 22.3% from $60,383 a year earlier.

Analysis

Virax Biolabs (VRAX) Finished Goods (2024 - 2025) Analysis & Trends

  • By fiscal year, Finished Goods came in at $60,383 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Virax Biolabs 866,746.23 -20.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 46,904.00
Sep 30, 2024 49,404.00
Mar 31, 2024 60,383.00
API Access

Virax Biolabs Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=VRAX&period=max&api_key=YOUR_API_KEY